Cite
MLA Citation
W Sandborn et al.. “OP33 Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S030–S031. http://access.bl.uk/ark:/81055/vdc_100130764680.0x000015